Loading...
Indian Pharmaceutical Exporter · #10 for Pyrantel · $39.3K export value · DGFT Verified
S D Pharmaceuticals is the #10 Indian exporter of Pyrantel with $39.3K in export value and 4 verified shipments. S D Pharmaceuticals holds a 1.2% market share in Pyrantel exports across 1 countries. The company exports 6 pharmaceutical products worth $753.6K across 5 therapeutic categories.
| CONGO | $107.6K | 6 | 3.6% |
| CONGO DR | $99.6K | 11 | 3.4% |
| FINLAND | $88.9K | 3 | 3.0% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $85.9K | 12 | 2.9% |
| TANZANIA | $85.9K | 18 | 2.9% |
| VENEZUELA | $62.8K | 7 | 2.1% |
India exports Pyrantel to 54 countries. The top destination is RUSSIA (33.9%), followed by UKRAINE and CANADA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HINCUS PHARMACEUTICALS | RUSSIA | $595.4K | 24 |
| GLADPHARM LTD. | UKRAINE | $418.5K | 16 |
| AO NPC ELFA | RUSSIA | $303.6K | 8 |
| GLADPHARM LIMITED | UKRAINE | $283.6K | 7 |
| JAMP PHARMA CORPORATION | CANADA | $180.5K | 6 |
| REGENCY PHARMA LIMITED | MAURITIUS | $148.3K | 36 |
| GLADPHARM LTD | UKRAINE | $116.4K | 4 |
| AO NPC ?ELFA | RUSSIA | $77.9K | 6 |
| SANTEVIE SARL | CONGO | $73.4K | 9 |
| AO NPC ELFA UGRESHSKAYA STREET | FINLAND | $64.5K | 2 |
India's Pyrantel is purchased by 127 buyers worldwide. The top buyer is HINCUS PHARMACEUTICALS (RUSSIA), followed by GLADPHARM LTD. and AO NPC ELFA.
India exported $2.8M worth of Pyrantel through 477 shipments from 70 suppliers to 54 countries, serving 127 buyers globally. S D Pharmaceuticals contributes $39.3K to this total, accounting for 1.2% of India's Pyrantel exports.
S D Pharmaceuticals's average Pyrantel shipment value is $9.8K per consignment, based on 4 shipments totaling $39.3K.
S D Pharmaceuticals ranks #10 among 70 Indian Pyrantel exporters with a 1.2% market share. The top 3 exporters are KUSUM HEALTHCARE PRIVATE LIMITED ($736.8K), IPCA LABORATORIES LIMITED ($637.0K), OXFORD LABORATORIES PRIVATE LIMITED ($539.4K). S D Pharmaceuticals processed 4 shipments to 1 destination countries.
What S D Pharmaceuticals must comply with to export Pyrantel to its top destination countries
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | ASHISH LIFE SCIENCE PRIVATE LIMITED | $56.4K | 20 | 7 | $2.8K |
| 9 | ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED | $40.8K | 8 | 2 | $5.1K |
| 10 | S.D.PHARMACEUTICALS ★ | $39.3K | 4 | 1 | $9.8K |
| 11 | ALFA BIOMED INDIA PRIVATE LIMITED | $38.7K | 27 | 2 | $1.4K |
| 12 | SAI PARENTERALS PRIVATE LIMITED | $30.8K | 7 | 1 | $4.4K |
S D Pharmaceuticals ranks #10 among 70 Indian Pyrantel exporters. Average shipment value of $9.8K compared to the market average of $40.5K. The closest competitors by value are ASHISH LIFE SCIENCE PRIVATE LIMITED and ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 104 | 21.8% |
| JNPT | 66 | 13.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 61 | 12.8% |
| NHAVA SHEVA SEA (INNSA1) | 53 | 11.1% |
| JNPT/ NHAVA SHEVA SEA | 38 | 8.0% |
| Bombay Air | 24 | 5.0% |
| NHAVA SHEVA SEA | 11 | 2.3% |
| HYDERABAD ICD | 10 | 2.1% |
S D Pharmaceuticals exports 6 products worth $753.6K. Beyond Pyrantel, top products include Bromhexine, Temozolomide, Amiodarone, Raltegravir, Atazanavir. View the complete S D Pharmaceuticals profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Pyrantel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 54+ countries, 127+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for S D Pharmaceuticals's Pyrantel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
S D Pharmaceuticals
Full Company Profile →
6 products · $753.6K total trade · 5 categories
Access shipment-level records, pricing trends, and buyer contacts for S D Pharmaceuticals.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrantel. For current shipment-level data, contact TransData Nexus.